期刊文献+

长链非编码RNA LOC100288637在原发性肝癌中差异性表达的生物学意义及相关机制研究 被引量:1

Research on the biological significance of the LncRNA LOC100288637 expression differences in primary hepatic carcinoma and the related mechanism
下载PDF
导出
摘要 目的研究长链非编码RNA(LncRNA)LOC100288637在肝癌中的表达差异,对肝癌细胞增殖的影响及相关机制。方法分析GEO数据集GSE58043和GSE10694,得出LOC100288637及hsa-miR-101-3p在肝癌组织中差异表达,RNA-hybrid分析LOC100288637与hsa-miR-101-3p的结合具有可能性。逆转录-聚合酶链式反应在组织和细胞水平检测LOC100288637表达量。荧光原位杂交观察LOC100288637在细胞中的定位。敲低LOC100288637后CCK-8检测细胞增殖情况。过表达hsamiR-101-3p后,检测LOC100288637的变化。结果LOC100288637在肝癌组织中的表达量高于癌旁组织(P<0.05);LOC100288637在肝癌细胞系中的表达量高于肝细胞系(P<0.05)。LOC100288637在HepG2细胞核质均有表达,以细胞质居多。敲低LOC100288637后HepG2细胞增殖活性降低(P<0.01)。过表达hsa-miR-101-3p后,LOC100288637表达量下降(P<0.05)。结论 LncRNA LOC100288637可能在肝癌发生,发展过程中起重要作用并接受hsa-miR-101-3p靶向调控影响肝癌细胞的增殖。 Objective To explore the expression differences of long noncoding RNA(LncRNA) LOC100288637 in liver cancer,the effect of LOC100288637 on liver cancer cell proliferation and the relevant mechanisms. Methods Based on the analysis of the GEO database data sets GSE58043 and GSE10694,we found that both LOC100288637 and hsa-miR-101-3p has obvious expression differences in liver cancer tissues. RNA hybrid revealed the possibility of combination between LOC100288637 and hsa-miR-101-3p; RT-PCR was performed to measure the expression level of LOC100288637 in tissues and cells; fluorescence in situ hybridization was used to observe LOC100288637 localization in cells;cell proliferation was determined by CCK8 experiment after LOC100288637 siRNA knock down. The expression of LOC100288637 in cells were measured after treated with hsa-miR-101-3p mimics. Results Relative quantitative expression of LOC100288637 in liver cancer tissues group was significantly higher than that in no tumor tissues group (P(0.05);relative quantitative expression of LOC100288637 in liver cancer cell lines were significantly higher than that in normal liver cell line(P(0.05). LOC100288637 was located in both cytoplasm and nucleus of HepG2 cells,and mainly in cytoplasm. Cell proliferation vitality of HepG2 reduced after treated with LOC100288637-siRNA(P〈0.01). Relative quantitative expression of LOC100288637 in HepG2 reduced after treated with hsa-miR-101-3p mimics (P (0. 05). Conclusion LncRNA LOC100288637 may play an important role in liver cancer development,it can be down regulated by hsa-miR-101-3p and affect the proliferation of liver cancer cells.
出处 《重庆医学》 CAS 北大核心 2016年第16期2198-2201,共4页 Chongqing medicine
基金 国家自然科学基金面上项目(81270523)
关键词 肝肿瘤 增殖 LOC100288637 101-3p liver neoplasms proliferation LOC100288637 miRNA-101-3p
  • 相关文献

参考文献15

  • 1Tomizawa M, Shinozaki F,Motoyoshi Y,et al.Suppres- sion of hepatocellular carcinoma cell proliferation by short hairpin RNA of frizzled 2 with Sonazoid-enhanced irradia- tion[J].Int J Oncol,2016 ,48(1): 123-129.
  • 2Wu YH , Ai X, Liu FY, et al.c-Jun N-terminal kinase in- hibitor favors transforming growth factorbeta to antago- nize hepatitis B virus X protein induced cell growth pro- motion in hepatocellular carcinoma[J].Mol Med Rep,2015,13(2):1345-1352.
  • 3Gai JQ,Sheng X,Qin JM,et al.The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell in- vasion and metastasis via Wnt/beta-catenin signaling pathway[J].Int J Oncol,2016 ,48(1): 338-348.
  • 4Lu X,Sun W,Tang Y,et al.Identification of key genes in hepatocellular carcinoma and validation of the candidate gene, cdc25a, using gene set enrichment analysis, meta- analysis and crossspecies comparison[J], Mol Med Rep, 2015,13(2):1172-1178.
  • 5Botti G, Marra L, Malzone MG, et al.LncRNA HOTAIR as prognostic circulating marker and potential therapeutic target in patients with tumor diseases[J].Curr Drug Tar- gets,2015(9):1.
  • 6Li L,Zhang L,Zhang Y,et al Increased expression of Ln- cRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer[J].Biomed Pharmacoth- er,2015(72):109-112.
  • 7Zhu S,Mao J, Shao Y,et al.Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance[J], Tumour Biol, 2015 ,36(10):8041-8045.
  • 8Zhou X, Yin C,Dang Y,et al.Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer[J], Sci Rep,2015(5): 11516.
  • 9Xu C,Shao Y, Xia T, et al.IncRNA-ACl30710 targeting by miR-129-5p is upregulated in gastric cancer and associ- ates with poor prognosis[J].Tumour Biol,2014,35(10):9701-9706.
  • 10Liang WC, Fu WM, Wong CW, et al.The IncRNA H19 promotes epithelial to mesenchymal transition by functio- ning as miRNA sponges in colorectal cancer[J], Oncotar- get,2015,6(26):22513-22525.

同被引文献20

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部